BioPharma Dive 8 déc. 2025 Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment
BioPharma Dive 8 déc. 2025 Dyne to seek Duchenne drug approval; Kymera, Wave and Structure shares soar
BioPharma Dive 5 déc. 2025 Hemophilia gene therapies are struggling on the market, even as innovation soars
BioPharma Dive 3 déc. 2025 After finding ‘irregularities,’ Bristol Myers to extend key trial of Cobenfy in Alzheimer’s psychosis